提供永久免费的API接口，查看更多API接口，如果您有其他免费API资源，请联系我们，造福人类。

定制开发，免费评估，免费咨询，价格便宜，售后保障，前往开发服务中心或联系开发客服中心

Share the QR code < / P > < p > with friends and circles of friends < / P > < p > on Wednesday, a senior Indian health official and chairman of the Indian Medical Research Council said that there were several "major safety problems" in the anti new crown medicine produced by the US MSD group, and the government did not include the drug in the national treatment plan < p > < / P > < p > on Wednesday local time, the head of India's major medical research institutions said that there were "major safety problems" in molnupiravir, the new crown oral drug of MSD, or it would prevent it from joining the country's virus treatment list < p > it is reported that molnupiravir, an oral drug of methadone, finally prevents virus replication by introducing different mechanisms into genetic material, but it may affect growing human cells < p > last week, the Indian drug regulatory authority has granted molnupiravir emergency use authorization to MSD, but Balram Bhargava, director general of ICMR of Indian Medical Research Council, said that the government has not decided whether to recommend molnupiravir < p > this drug has major safety problems. (this drug) can cause deformity, or cause defects, mutations, or permanent transmissible changes in the structure of cellular genetic material in developing fetuses, cartilage damage, and possibly muscle damage. Contraceptive measures must also be taken for people taking this drug, both men and women, because children born may have teratogenic problems < p > in December, Wall Street heard that molnupiravir was authorized by FDA for emergency use. Not long ago, Pfizer's new crown oral drug was also approved by FDA. However, the FDA also said that pregnant women are not recommended to use the new crown drug of methadone < p > previously, FDA approved the emergency use authorization of new crown drug of methadone according to the treatment of 1433 patients. Compared with placebo, the company's oral anti new crown drug molnupiravir showed a 30% relative risk reduction in the patients participating in the trial < p > at the end of November, molnupiravir, a new oral drug of MSD, was supported by the FDA advisory committee, which recommended that FDA grant molnupiravir emergency use authorization. At that time, the FDA advisory committee voted 13 to 10 to support the new crown oral drug of methadone, saying that the benefits outweighed the risks. Members who voted against raised concerns about the safety of drugs, especially for pregnant women < p > Bhargava also pointed out that at present, the new crown drug of methadone has not been widely accepted worldwide: < / P > < p > it has not been included by who and has not been included in the UK so far. The current recommendation is that it does not fall within the scope of national treatment < p > Bhargava's criticism of molnupiravir may also involve India's huge pharmaceutical industry. Indian Health Minister mansukh mandaviya said last week that 13 companies would produce molnupiravir in India for the treatment of adult new crown patients, but only limited to "limited use" in emergencies < p > it is reported that on January 4, Dr Reddy's Laboratories Ltd, an Indian pharmaceutical company, announced that it would launch molnupiravir's generic drug, priced at 35 rupees (US $0.4693) per pill. The company expects to supply pharmacies across India from the beginning of next week < p > as of the issuance of the document, Mosha East has increased by 0.36% in one day and 2.99% since the beginning of the year. Earlier articles on Wall Street mentioned that Buffett's Berkshire cleared its positions in mursadong in the third quarter

2023-03-22 10:04:48